Europe — EMA

Oxaliplatin Actavis

Oxaliplatin, the active ingredient in Oxaliplatin Actavis, is a platinum compound presented as a sterile solution for intravenous infusion use.

Oxaliplatin

Request sourcing

Pack/s

What is Oxaliplatin?

Oxaliplatin, the active ingredient in Oxaliplatin Actavis, is a platinum compound presented as a sterile solution for intravenous infusion use. It is employed in the treatment of colorectal cancer, typically administered to adult patients undergoing combination chemotherapy regimens. GNH USA supplies Oxaliplatin Actavis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

What is Oxaliplatin used for?

Oxaliplatin Actavis is a platinum‑based chemotherapy agent used primarily for cancers of the gastrointestinal tract and related tissues. - Colorectal cancer: Enhances the efficacy of standard F‑F regimens by inducing tumour cell death. - Gastric cancer: Used in combination with flu‑‑ S S S ".". - Advanced Ad Ad ". - ")."

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →